Following menopause, women are generally at higher risk for osteoporosis (bone loss) as a result of experiencing hormone imbalances that can weaken bones. In a controlled study, scientists set out to examine bone density in women who stopped taking oral estrogen hormone therapy and replaced it with estrogen and testosterone implants.
The study involved 20 women who had already been taking oral estrogen replacement pills for a number of years. 10 of the women were instructed to stop taking oral estrogen treatment and were administered estrogen and testosterone implants, while the other 10 women continued to take oral estrogen. At the end of the 1-year study, the women with hormone implants experienced over a 5% increase in bone density, whereas the women taking oral treatments experienced no changes in bone density.
For more information, read the full article: Hormone implants lead to increase in bone mass